Investigating health effects of fibre consumption in healthy humans

Authors
Category Primary study
Registry of TrialsANZCTR
Year 2019
INTERVENTION: The study has a cross‐over design in which participants are randomised to complete a intervention diet and control diet in random order. The intervention diet is a 5‐day high‐fibre dietary intervention provided in the form of meals to study participants. Participants are provided with 3 main meals day (breakfast, lunch, dinner) and 2 snack items a day (morning tea, afternoon tea). Participants may also eat other foods outside of the provided diet but are given a list of recommended snack foods to help them follow the intervention diet as best as possible. Meals have been developed with a dietitian to ensure they are nutritionally balanced and are cooked by a research chef in a commercial grade kitchen. Meals are portioned, vacuum‐sealed and then provided to participants frozen. Participants are given study food diaries to follow and to help assess compliance. The average amount of energy provided by the study meals/snacks is 9277 kj/day. The average amount of total fibre is 39 g/day all of which is naturally contained in the foods provided. These are mainly in the form of resistant starch (7 g/day) and fermentable oligosaccharides (7 g/day). Meals for the high fibre diet high in legumes, wholegrains, fruits and vegetables. Example foods include Rye bread, wholegrain cereals (wheat bran), brown rice, split peas, pear and cannellini beans. These figures have been calculated through the use of food composition software (Foodworks). Once completed, there is a 5‐day wash‐out period between the diets. CONDITION: Diet and Nutrition ‐ Other diet and nutrition disorders Gut disease;Asthma;Inflammatory Bowel Disease;Allergies; ; Gut disease ; Asthma ; Inflammatory Bowel Disease ; Allergies Inflammatory and Immune System ‐ Normal development and function of the immune system Metabolic and Endocrine ‐ Normal metabolism and endocrine development and function Oral and Gastrointestinal ‐ Inflammatory bowel disease PRIMARY OUTCOME: Blood Short‐chain fatty acid level[Morning of Day 5 of intervention and control diet] SECONDARY OUTCOME: Proportion of peripheral blood T‐regulatory cells[Morning of Day 5 of intervention and control diet] This is a composite secondary outcome measuring Blood cytokine levels. ; Interleukin (IL)‐10, IL‐17A, IL‐1B, IL‐6, IL‐8 and Tumour necrosis factor (TNF)‐a ; Measured by multiplex analysis [Morning of day 5 of intervention and control diet] INCLUSION CRITERIA: Healthy adults
Epistemonikos ID: eaa0905c0ff20f7c13a7648a02222d789b21c8eb
First added on: Aug 24, 2024